Skip to main content

Association of stage shift and population mortality among patients with non–small cell lung cancer

ByRaja Flores, Parth Patel, Naomi Alpert, Bruce Pyenson, and Emanuela Taioli
23 December 2021

There is a stage shift for non-small cell lung cancer that could substantially confound the evaluation of newer therapeutics and mortality outcomes. This study found that the stage shift from later to earlier stage disease over the last decade was associated with improved mortality among people with lung cancer. 

This article was originally published in JAMA Network Open.

Read the article.


Explore more tags from this article

About the Author(s)

Raja Flores

Parth Patel

Naomi Alpert

Emanuela Taioli

We’re here to help